GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biodexa Pharmaceuticals Plc (NAS:BDRX) » Definitions » Total Operating Expense

Biodexa Pharmaceuticals (Biodexa Pharmaceuticals) Total Operating Expense : $5.47 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Biodexa Pharmaceuticals Total Operating Expense?

Biodexa Pharmaceuticals's Total Operating Expense for the six months ended in Dec. 2023 was $2.58 Mil. Biodexa Pharmaceuticals's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $5.47 Mil.


Biodexa Pharmaceuticals Total Operating Expense Historical Data

The historical data trend for Biodexa Pharmaceuticals's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biodexa Pharmaceuticals Total Operating Expense Chart

Biodexa Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.44 6.65 3.89 5.51 5.48

Biodexa Pharmaceuticals Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.72 2.26 3.27 2.89 2.58

Biodexa Pharmaceuticals Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $5.47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biodexa Pharmaceuticals Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Biodexa Pharmaceuticals's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Biodexa Pharmaceuticals (Biodexa Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
1 Caspian Point, Caspian Way, Cardiff, GBR, CF10 4DQ
Biodexa Pharmaceuticals Plc is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and development medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

Biodexa Pharmaceuticals (Biodexa Pharmaceuticals) Headlines

From GuruFocus

Midatech Pharma PLC Announces Results of General Meeting

By ACCESSWIRE ACCESSWIRE 03-24-2023